Posted in | News | Plastics and Polymers | Business

Degussa and Celanese Establish Joint Venture

Nov 28 2002

Related Stories

Degussa AG and Celanese AG have successfully negotiated the establishment of a joint venture, in which both companies will hold a 50% stake.

The Joint venture will merge Degussa’a Oxeno subsidiary in Marl, Germany, with Celanese’s C3-oxo business activities in Oberhausen, also in Germany. Together they will produce propylene-based oxo chemicals in Europe for use as chemical intermediates in solvents and plasticisers.

The conditions of the agreement are expected to take effect immediately after being granted permission by regulatory bodies. The parties involved expect this to take place some time in 2003.

For more information on plasticisers, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback